Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts

doi:10.12998/wjcc.v12.i1.32

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3053)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1874

Figures (1-4)

254

Tables (1-1)

218

Sum=2435

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

441

Sum=522

Jan 6, 2024 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jan 6, 2024; 12(1): 32-41
Published online Jan 6, 2024. doi: 10.12998/wjcc.v12.i1.32

Full Size Figure Download Figure

Figure 4 Nomogram for predicting 3-year progress free interval of prostate cancer. PSA: Prostate-specific antigen; MKI67: Marker Ki-67.

Citation: Song Z, Zhou Q, Zhang JL, Ouyang J, Zhang ZY. Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases 2024; 12(1): 32-41
URL: https://www.wjgnet.com/2307-8960/full/v12/i1/32.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i1.32